Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	121	228	115	288	167	116
Market Cap Growth	3.85%	97.92%	-59.89%	72.07%	44.02%	-2.10%
Enterprise Value	158	267	165	337	216	172
PE Ratio	-	-66.88	-12.13	-999.01	-21.41	-24.77
PS Ratio	1.13	2.04	1.02	2.42	1.64	1.00
PB Ratio	1.76	3.13	1.60	3.45	2.18	1.42
P/FCF Ratio	11.21	19.49	-263.45	4294.24	20.44	17.00
P/OCF Ratio	8.90	16.28	100.17	227.98	17.92	14.43
EV/Sales Ratio	1.48	2.38	1.46	2.83	2.12	1.48
EV/EBITDA Ratio	72.64	33.22	174.92	37.34	41.87	22.54
EV/EBIT Ratio	-45.32	257.85	-24.90	240.61	-87.97	-1872.08
EV/FCF Ratio	14.64	22.78	-377.00	5027.66	26.47	25.22
Debt / Equity Ratio	0.60	0.59	0.75	0.68	0.75	0.79
Debt / EBITDA Ratio	18.98	5.32	57.46	6.31	11.14	8.44
Debt / FCF Ratio	3.83	3.65	-123.84	850.15	7.04	9.44
Quick Ratio	0.76	0.77	0.91	1.17	1.24	1.15
Current Ratio	1.88	1.85	2.20	2.43	2.46	2.12
Asset Turnover	0.77	0.79	0.75	0.77	0.67	0.70
Interest Coverage	-1.45	0.29	-2.60	0.91	-0.51	-0.02
Return on Equity (ROE)	-12.00%	-4.60%	-12.80%	-0.40%	-10.20%	-5.90%
Return on Assets (ROA)	-6.30%	-2.40%	-6.30%	-0.20%	-5.10%	-2.80%
Return on Capital (ROIC)	-1.94%	1.63%	-5.48%	1.47%	0.16%	0.26%
Earnings Yield	-7.21%	-1.50%	-8.25%	-0.10%	-4.67%	-4.04%
FCF Yield	8.92%	5.13%	-0.38%	0.02%	4.89%	5.88%
Buyback Yield / Dilution	-1.45%	-2.43%	-2.65%	-4.41%	-2.18%	-3.73%
Total Shareholder Return	-1.45%	-2.43%	-2.65%	-4.41%	-2.18%	-3.73%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).